| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash | 6,049,084 | 6,640,468 | ||
| Advances on research and development contract services | 220,286 | 208,972 | ||
| Prepaid insurance | 71,429 | 142,776 | ||
| Prepaid expenses | 10,000 | 10,000 | ||
| Total current assets | 6,350,799 | 7,002,216 | ||
| Total assets | 6,350,799 | 7,002,216 | ||
| Accounts payable and accrued expenses | 333,081 | 403,729 | ||
| Warrant liability | 1,201 | 2,413 | ||
| Total current liabilities | 334,282 | 406,142 | ||
| Total liabilities | 334,282 | 406,142 | ||
| Common stock, 0.001 par value per share 100,000,000 shares authorized 1,795,260 and 492,417 shares issued and outstanding at september 30, 2025 and december 31, 2024, respectively | 1,795 | 1,685 | ||
| Additional paid-in capital | 93,460,448 | 93,373,378 | ||
| Accumulated deficit | -87,445,726 | -86,778,989 | ||
| Total stockholders equity | 6,016,517 | 6,596,074 | ||
| Total liabilities and stockholders equity | 6,350,799 | 7,002,216 | ||
Bone Biologics Corp (BBLGW)
Bone Biologics Corp (BBLGW)